CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,220,045 | -24.7% | 26,879 | -6.9% | 0.00% | 0.0% |
| Q2 2023 | $1,620,262 | +21.3% | 28,861 | -2.3% | 0.00% | 0.0% |
| Q1 2023 | $1,336,233 | +9.7% | 29,543 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $1,218,005 | -36.1% | 29,963 | +2.7% | 0.00% | -33.3% |
| Q3 2022 | $1,906,000 | +35.8% | 29,166 | +26.3% | 0.00% | +50.0% |
| Q2 2022 | $1,404,000 | -33.5% | 23,096 | -31.3% | 0.00% | -33.3% |
| Q1 2022 | $2,111,000 | -5.2% | 33,625 | +14.4% | 0.00% | 0.0% |
| Q4 2021 | $2,227,000 | -43.8% | 29,391 | -17.0% | 0.00% | -50.0% |
| Q3 2021 | $3,965,000 | +9.3% | 35,422 | +58.0% | 0.01% | +20.0% |
| Q2 2021 | $3,629,000 | +32.4% | 22,418 | -0.3% | 0.01% | 0.0% |
| Q1 2021 | $2,740,000 | +6.5% | 22,490 | +33.9% | 0.01% | 0.0% |
| Q4 2020 | $2,572,000 | +143.3% | 16,801 | +33.0% | 0.01% | +150.0% |
| Q3 2020 | $1,057,000 | +20.9% | 12,635 | +6.2% | 0.00% | 0.0% |
| Q2 2020 | $874,000 | +67.4% | 11,893 | -3.2% | 0.00% | +100.0% |
| Q1 2020 | $522,000 | -26.0% | 12,281 | +6.2% | 0.00% | 0.0% |
| Q4 2019 | $705,000 | +76.2% | 11,562 | +18.0% | 0.00% | 0.0% |
| Q3 2019 | $400,000 | +0.3% | 9,795 | +18.0% | 0.00% | 0.0% |
| Q2 2019 | $399,000 | – | 8,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |